The financial crisis since 2007/2008 and the far-reaching consequences for the national debts demonstrated that national regulatory authorities had major problems in determining crucial issues in the scope of over the counter derivatives. On the one hand, it seemed nearly impossible to detect agglomerations of systemic risks due to enormous lacks in transparency. On the other hand, the regulation of over the counter derivatives neither was harmonized on an international basis nor were the existing regulations sufficient to encourage stability in the financial system. Because of the multinational interdependence between financial institutions, a regulation in the scope of over the counter derivatives had to be initiated on harmonized, international basis. Due to this fact, the G20-states issued the following statement on the G20-summit in Pittsburgh in 2009:„All standardized OTC derivative contracts should be traded on exchanges or electronic trading platforms, where appropriate, and cleared through central counterparties by end-2012 at the latest. OTC derivative contracts should be reported to trade repositories. Non-centrally cleared contracts should be subject to higher capital requirements. We ask the FSB and its relevant members to assess regularly implementation and whether it is sufficient to improve transparency in the derivatives markets, mitigate systemic risk, and protect against market abuse.“The target of this paper is to summarize the implementations of the FSB proposals in the USA, Europa and Asia, which is represented through Hong Kong, Japan and Australia. Furthermore, the consequences for the financial markets as well as the market participants are discussed. The result of this paper is that the original objectives, an increase in the financial stability and the reduction of systemic risks, are, in the scope of over the counter derivatives, only partially obtained.